Cargando…
Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis
BACKGROUND AND AIMS: Curative surgery saves ≈50% of all patients with colorectal cancer (CRC) while remaining patients have synchronous or will develop metachronous metastases. Presently, the single most important prognostic factor is histopathological detection of disseminated tumor cells in region...
Autores principales: | Olsson, Lina, Hammarström, Marie-Louise, Israelsson, Anne, Lindmark, Gudrun, Hammarström, Sten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015415/ https://www.ncbi.nlm.nih.gov/pubmed/32049988 http://dx.doi.org/10.1371/journal.pone.0229007 |
Ejemplares similares
-
Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
por: AbdelMageed, Manar, et al.
Publicado: (2021) -
CEACAM5, KLK6, SLC35D3, POSTN, and MUC2 mRNA Analysis Improves Detection and Allows Characterization of Tumor Cells in Lymph Nodes of Patients Who Have Colon Cancer
por: Olsson, Lina M., et al.
Publicado: (2021) -
The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome
por: AbdelMageed, Manar, et al.
Publicado: (2019) -
Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer
por: Ohlsson, L, et al.
Publicado: (2012) -
Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT–PCR
por: Ohlsson, L, et al.
Publicado: (2006)